1. Home
  2. SKYH vs AVXL Comparison

SKYH vs AVXL Comparison

Compare SKYH & AVXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sky Harbour Group Corporation

SKYH

Sky Harbour Group Corporation

N/A

Current Price

$8.97

Market Cap

324.6M

Sector

Industrials

ML Signal

N/A

Logo Anavex Life Sciences Corp.

AVXL

Anavex Life Sciences Corp.

N/A

Current Price

$4.64

Market Cap

388.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SKYH
AVXL
Founded
2017
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Military/Government/Technical
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
324.6M
388.7M
IPO Year
N/A
2013

Fundamental Metrics

Financial Performance
Metric
SKYH
AVXL
Price
$8.97
$4.64
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
3
Target Price
$13.83
$22.00
AVG Volume (30 Days)
128.0K
1.0M
Earning Date
01-01-0001
04-27-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$95.29
N/A
Revenue Next Year
$69.22
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$8.22
$2.86
52 Week High
$14.20
$13.99

Technical Indicators

Market Signals
Indicator
SKYH
AVXL
Relative Strength Index (RSI) 47.83 56.02
Support Level $8.33 $3.60
Resistance Level $10.69 $4.88
Average True Range (ATR) 0.31 0.26
MACD 0.02 0.05
Stochastic Oscillator 28.35 55.88

Price Performance

Historical Comparison
SKYH
AVXL

About SKYH Sky Harbour Group Corporation

Sky Harbour Group Corp is an aviation infrastructure company building a nationwide network of Home-based solutions for business aircraft. The company develops, leases, and manages business aviation hangars across the United States based on its proprietary targeting and acquisition model, targeting airfields with hangar supply and demand imbalances in the markets. Its hangar campuses feature exclusive private hangars and a full suite of dedicated services specifically designed for home-based aircraft.

About AVXL Anavex Life Sciences Corp.

Anavex Life Sciences Corp is a clinical stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system(CNS) diseases with high unmet need. It analyzes genomic data from clinical trials to identify biomarkers, which are used in the analysis of its clinical trials for the treatment of neurodegenerative and neurodevelopmental diseases. The company focuses on developing treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders. Its pipeline includes ANAVEX 2-73 and ANAVEX 3-71 and several other compounds in different stages of clinical and pre-clinical development.

Share on Social Networks: